Literature DB >> 14041

Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.

K Pollow, E Boquoi, J Baumann, M Schmidt-Gollwitzer, B Pollow.   

Abstract

Specific activity of 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) was measured in 48 tissue specimens of human female breast cancer and, in addition, 48 nonmalignant tissue specimens obtained in each case from the same cancer-bearing breast. In all cases the nonmalignant tissue showed greater conversion of estradiol-17 beta into estrone than the neoplastic tissues. In normal human breast tissue of premenopausal women specific enzyme activity depended on the phase of the MENSTRUAL CYCLE: the highest values of 17 beta-HSD activity were found in the early secretory phase. To determine the intracellular distribution of the 17 beta-HSD, purified microsomes, mitochondria, peroxysomes, lysosomes, nuclei and cytosol fractions were prepared. The purity of each fraction was monitored by marker enzymes. It was found that the 17 beta-HSD was mainly located in mitochondria and microsomes. Furthermore it could be demonstrated that the microsomal enzyme was bound tightly to the membranes of the endoplasmic reticulum, while the mitochondrial 17 beta-HSD was mainly associated with the outer membranes of the organelle. Kinetic parameters (Km-values, coenzyme requirements and maximal velocities) of a cytoplasmic, nuclear, mitochondrial and microsomal 17 beta-HSD of normal and neoplastic human mammary tissue were compared. Maximal velocity was highest in enzyme preparations of normal mammary tissue obtained from premenopausal women in the early secretory phase. Km-values wrere nearly identical in normal and neoplastic mammary tissue preparations (approx. 1 X 10(-6) M). NAD was more efficient than NADP as a cofactor. For the conversion of estradiol to estrone the optimum temperature was approximately 40 degrees C and the optimum pH 9.5. For the reduction of estrone the optimum pH was 6.5. Sulphydryl groups were shown to be essential for catalysis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14041     DOI: 10.1016/0303-7207(77)90108-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

Review 1.  Factors influencing estrogen production and metabolism in postmenopausal women with endocrine cancer.

Authors:  V H James; E J Folkerd; R C Bonney; P A Beranek; M J Reed
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

2.  Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).

Authors:  B L Nguyen; G Chetrite; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

3.  17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.

Authors:  T Suzuki; T Moriya; N Ariga; C Kaneko; M Kanazawa; H Sasano
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

4.  Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

Authors:  N T Telang; F Arcuri; O M Granata; H L Bradlow; M P Osborne; L Castagnetta
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

5.  Effect of hormone manipulation on oxidation, reduction and sulphurylation of dehydroepiandrosterone and oestrone in DMBA-induced rat mammary tumours.

Authors:  K Li; D P Chandra; T Pewnim; T Foo; J B Adams
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.